Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-24 @ 5:39 PM
NCT ID:
NCT03789968
Eligibility Criteria:
Inclusion Criteria:
1. HIV diagnosis
2. 18 years of age or older
3. Receiving ART for at least 3 months
4. ART is switched to bictegravir/emtricitabine/tenofovir alafenamide between 2/7/2018 and 3/30/2019
5. Patient is receiving at least one chronic or as needed non-ART medication at the time of the switch
Exclusion Criteria:
\-
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03789968
Study Brief:
Protocol Section:
NCT03789968